{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:24:39Z","timestamp":1790871879829,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.diabres.2022.110023","type":"journal-article","created":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T21:46:41Z","timestamp":1658958401000},"page":"110023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in Ireland"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6127-5049","authenticated-orcid":false,"given":"Delia","family":"Bogdanet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Toth Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Doheny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Dervan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Angel Luque-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula M.","family":"O'Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidelma P.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.diabres.2022.110023_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10061257","article-title":"Screening for Gestational Diabetes Mellitus in Early Pregnancy: What Is the Evidence?","volume":"10","author":"Raets","year":"2021","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.diabres.2022.110023_b0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5694\/mja17.01129","article-title":"Hyperglycaemia in early pregnancy: the Treatment of Booking Gestational diabetes Mellitus (TOBOGM) study. A randomised controlled trial","volume":"209","author":"Simmons","year":"2018","journal-title":"Med J Aust"},{"issue":"2","key":"10.1016\/j.diabres.2022.110023_b0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/AOG.0000000000002726","article-title":"Research Gaps in Gestational Diabetes Mellitus: Executive Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop","volume":"132","author":"Wexler","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.diabres.2022.110023_b0020","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF02918257","article-title":"Membrane defence against complement lysis: the structure and biological properties of CD59","volume":"12","author":"Davies","year":"1993","journal-title":"Immunol Res"},{"issue":"8","key":"10.1016\/j.diabres.2022.110023_b0025","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ajh.23478","article-title":"A specific and sensitive assay for blood levels of glycated CD59: a novel biomarker for diabetes","volume":"88","author":"Ghosh","year":"2013","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.diabres.2022.110023_b0030","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2337\/dc16-2598","article-title":"Plasma Glycated CD59, a Novel Biomarker for Detection of Pregnancy-Induced Glucose Intolerance","volume":"40","author":"Ghosh","year":"2017","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.diabres.2022.110023_b0035","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa087","article-title":"Plasma Glycated CD59 Predicts Early Gestational Diabetes and Large for Gestational Age Newborns","volume":"105","author":"Ma","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.diabres.2022.110023_b0040","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s12884-020-03090-9","article-title":"Plasma glycated CD59 (gCD59), a novel biomarker for the diagnosis, management and follow up of women with Gestational Diabetes (GDM) - protocol for prospective cohort study","volume":"20","author":"Bogdanet","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"10.1016\/j.diabres.2022.110023_b0045","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/dc09-1848","article-title":"International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy","volume":"33","author":"Metzger","year":"2010","journal-title":"Diabetes Care"},{"issue":"5 Suppl","key":"10.1016\/j.diabres.2022.110023_b0050","first-page":"13","article-title":"Atlantic DIP: the prevalence and consequences of gestational diabetes in Ireland","volume":"105","author":"O'Sullivan","year":"2012","journal-title":"Ir Med J"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2022.110023_b0055","first-page":"S5","article-title":"Executive summary: Standards of medical care in diabetes\u20132014","volume":"37","author":"Association","year":"2014","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.diabres.2022.110023_b0065","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0002-9378(82)90349-0","article-title":"Criteria for screening tests for gestational diabetes","volume":"144","author":"Carpenter","year":"1982","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.diabres.2022.110023_b0070","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s001250051487","article-title":"Glucose-induced loss of glycosyl-phosphatidylinositol-anchored membrane regulators of complement activation (CD59, CD55) by in vitro cultured human umbilical vein endothelial cells","volume":"43","author":"Accardo-Palumbo","year":"2000","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.diabres.2022.110023_b0075","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2337\/dc20-2360","article-title":"Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 Diabetes","volume":"44","author":"Meek","year":"2021","journal-title":"Diabetes Care"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:24:40Z","timestamp":1759173880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722008373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":14,"alternative-id":["S0168822722008373"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110023","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in Ireland","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110023"}}